Pediatric
The Pediatric/Developmental Ophthalmology Service consists of the Division of Pediatric/Developmental Ophthalmology and the Childrens Eye Medical and Surgical Group at Childrens Hospital Los Angeles (CHLA), including a program developed in association with CHLA, the Institute for Families of Blind Children, as well as the Pediatric Ophthalmology Clinic as the LAC+USC Medical Center, Outpatient Department. A full range of diagnostic and treatment methodologies are available through Doheny's ancillary and orthoptic service departments. Faculty members on this service have modified a behavioral technique, Forced Preferential Looking (FPL), for measuring visual acuity in infants and preverbal children. In addition to offering the full range of pediatric ophthalmology care, this service specializes in diagnosis and treatment of ocular oncology, neuro-ophthalmology, retinal disorders and strabismus.
 

Mark S. Borchert, M.D.
Dr. Borchert earned an M.D. from Baylor College of Medicine. He completed his residency at the Doheny Eye Institute, University of Southern California and a fellowship at the Massachusetts Eye & Ear Infirmary, Harvard University. Dr. Borchert specializes in Pediatric Neuro-Ophthalmology. His research on the development of the retina and optic nerve in rats was part of a recent experiment on the NASA space shuttle. Dr. Borchert is an Associate Professor at the USC Keck School of Medicine.

 

 

Talia Kolin
Dr. Kolin earned an M.D. From Mount Sinai School of Medicine, New York, New York. She completed her residency at White Memorial Medical Center, Los Angeles, California, and her fellowship at Childrens Hospital of Los Angeles.

 

 

A. Linn Murphree, M.D.
Dr. Murphree earned an M.D. from Baylor College of Medicine. He completed three fellowships: one at the University of Copenhagen, another at Baylor College of Medicine, and the third at Wilmer Ophthalmological Institute, Johns Hopkins Hospital. Dr. Murphree is a Professor of Ophthalmology and Pediatrics at the USC Keck School of Medicine and leads the development of a world-class Ocular Oncology Service at Childrens Hospital of Los Angeles and at the Doheny Eye Institute. Dr. Murphree and his colleagues have also developed new protocols for the treatment of retinoblastoma. He co-chairs the Retinoblastoma Study (RBS), a planned international multicenter clinical trial.

   

Jonathan Song, M.D.
Dr. Song earned an M.D. from University of California San Francisco. He completed his residency at University of Southern California / Doheny Eye Institute. He also served as chief resident during his residency. He completed two fellowships: a fellowship in pediatric ophthalmology at Childrens Hospital Los Angeles and a fellowship in Comea / Refractive Surgery at Doheny Eye Institute.